A study led by Prof. Liang Xingjie’s team from the National Center for Nanoscience and Technology of the Chinese Academy of Sciences (CAS) reported a biomimetic physical barrier (BPB) that temporarily blocks T cell-tumor cell interactions, effectively delaying T cell exhaustion and enabling a stronger, more sustained immune response, which represents a step forward for improving cancer immunotherapy outcomes.
This article was originally published on MedicalXpress.com